Blue Earth Team


  • Jonathan Allis's photo
    Jonathan Allis

    Chief Executive Officer

    Jonathan Allis is the founding CEO of Blue Earth Diagnostics. Prior to this role, Jonathan was the General Manager for PET at GE Healthcare Life Sciences, and had global responsibility for GE Healthcare’s PET agent and PET synthesis platforms business. He has previously held positions in R&D, Marketing and Product Development at GE Healthcare, Amersham plc, Siemens Medical Solutions and Oxford Magnet Technology, in the UK, USA and Germany.

    Jonathan is co-chair of the Society of Nuclear Medicine and Molecular Imaging Value Initiative Industry Alliance for 2018 – 2019.

    Jonathan has an undergraduate degree in Physics from the University of Cape Town and a doctorate in Biochemistry from the University of Oxford.

  • Helen Barker's photo
    Helen Barker

    Director of Regulatory Affairs

    Helen Barker is Director of Regulatory Affairs at Blue Earth Diagnostics. Helen has over twenty years’ experience in the management of regulatory affairs for the global pharmaceutical industry. She has deep sector expertise, having worked at levels of increasing seniority with a number of leading pharmaceutical companies including GSK, Janssen and Abbvie. Helen graduated from the University of Warwick with a degree in Microbiology and Microbial Technology, and has a PhD from Southampton University, where she studied the mechanism of action of antimicrobial peptides.

  • Ted Broadbent's photo
    Ted Broadbent

    Global Brand Director

    Ted Broadbent is Global Brand Director at Blue Earth Diagnostics. Before joining Blue Earth Diagnostics, Ted managed the PET Network for GE Healthcare Life Sciences in Europe, Middle East and Africa. He has previously held positions in sales, marketing, R & D and business development at GE Healthcare, Amersham plc., Molecular Dynamics, BTTG and Bio/Gene. Ted has an undergraduate degree in Life Sciences from the University of Liverpool and a doctorate in Molecular Pathology from the University of Leeds.

  • Peter Gardiner's photo
    Peter Gardiner

    Chief Medical Officer

    Peter Gardiner is the Chief Medical Officer at Blue Earth Diagnostics. He has more than 30 years’ experience in clinical development and medical affairs gained from roles at BG Medicine, Bristol-Myers Squibb Medical Imaging, DuPont Pharmaceuticals, Gensia and GD Searle.  Most recently, he was Vice President, Medical Affairs for Blue Earth Diagnostics in the United States.   Peter qualified in medicine from the University of Leeds and is Member of the Royal College of Physicians and a Fellow of its Faculty of Pharmaceutical Medicine. He is also a scientific advisor on medical imaging to global biopharmaceutical services company PAREXEL.

  • David Gauden's photo
    David Gauden

    Chief Scientific Officer

    David Gauden is the Chief Scientific Officer at Blue Earth Diagnostics. Prior to joining Blue Earth he was Product Leader for oncology molecular imaging at GE Healthcare, with business responsibility for the portfolio mix, licensing, product development and strategic marketing activities for a range of developmental PET drugs. Now with more than 20 years in the medical imaging industry, David has deep expertise across the business spectrum. He held roles of increasing seniority within supply chain, project management, IP licensing and clinical development. David has an undergraduate degree from the University of Warwick and a doctorate in Biochemistry from the University of Oxford.

  • Mike Heslop's photo
    Mike Heslop

    President of BED Inc.

    Mike Heslop is the President of Blue Earth Diagnostics Inc and has more than 25 years of experience in commercial and general management with Glaxo Wellcome USA, Genzyme Corporation and most recently Lantheus Medical Imaging where he was Vice President Business Development and Strategy. While at Genzyme, Mike held the positions of Senior Vice President & General Manager of the Biosurgery and Endocrine businesses, and Vice President, Global Marketing, PGH Business. Mike received a B.Sc. degree in Biology for McGill University and an M.B.A. from Concordia University.

  • Jim Martin's photo
    Jim Martin

    Chief Financial Officer

    Jim Martin is the Chief Financial Officer at Blue Earth Diagnostics. After completing his accountancy training with Deloitte, Jim has many years’ experience in Life Sciences and Medical Diagnostics with Amersham Plc and GE Healthcare. He has held a number of senior finance, commercial and operational roles and has lived and worked internationally in the United States and Scandinavia. He is a Chartered Accountant and qualified Corporate Treasurer with a degree in Business.

  • Matthew Miller's photo
    Matthew Miller

    Head of Imaging and Project Management

    Matthew Miller is the Head of Imaging and Project Management at Blue Earth Diagnostics. Prior to this role, Matthew was a Project Leader within the Imaging R&D division at GE Healthcare and Amersham plc., overseeing PET oncology clinical trials in Europe, the United States and Asia. He has previously held positions as a Principal Medical Physicist within Imaging R&D, GE Healthcare, and as a Nuclear Medicine Physicist at the Royal London Hospital, London. Matthew has a BSc in Theoretical Physics from the University of Nottingham, an MSc in Medical Physics from the University of Surrey and a PhD in Medical Physics from the Medical Research Council Cyclotron Unit, Hammersmith Hospital, London, in association with the University of Surrey.

  • Kathy Nagle's photo
    Kathy Nagle

    Head of Manufacture/Supply Chain and Quality Assurance

    Kathy Nagle is responsible for managing the manufacture and supply chain at Blue Earth Diagnostics. Prior to this role Kathy was European PET QA Manager at GE Healthcare. After post-doctoral work at the University of Ottawa, she joined Amersham International (subsequently incorporated into GE Healthcare) in 1989 as a Development Scientist. Kathy has held a series of increasingly senior roles in GE Healthcare within R&D, QC & QA. Kathy has an undergraduate degree in Chemistry and a doctorate in Organic Chemistry from the University of Bristol.